Distinct phenotypic differences associated with differential amplification of receptor tyrosine kinase genes at 4q12 in glioblastoma.
about
Targetable signaling pathway mutations are associated with malignant phenotype in IDH-mutant gliomas.The three receptor tyrosine kinases c-KIT, VEGFR2 and PDGFRα, closely spaced at 4q12, show increased protein expression in triple-negative breast cancer.KDR Amplification Is Associated with VEGF-Induced Activation of the mTOR and Invasion Pathways but does not Predict Clinical Benefit to the VEGFR TKI Vandetanib.Concurrence of chromosome 3 and 4 aberrations in human uveal melanoma.Involvement of platelet-derived growth factor ligands and receptors in tumorigenesis.Genetic and Epigenetic Features of Rapidly Progressing IDH-Mutant Astrocytomas
P2860
Distinct phenotypic differences associated with differential amplification of receptor tyrosine kinase genes at 4q12 in glioblastoma.
description
2013 nî lūn-bûn
@nan
2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Distinct phenotypic difference ...... genes at 4q12 in glioblastoma.
@ast
Distinct phenotypic difference ...... genes at 4q12 in glioblastoma.
@en
type
label
Distinct phenotypic difference ...... genes at 4q12 in glioblastoma.
@ast
Distinct phenotypic difference ...... genes at 4q12 in glioblastoma.
@en
prefLabel
Distinct phenotypic difference ...... genes at 4q12 in glioblastoma.
@ast
Distinct phenotypic difference ...... genes at 4q12 in glioblastoma.
@en
P2093
P2860
P1433
P1476
Distinct phenotypic difference ...... genes at 4q12 in glioblastoma.
@en
P2093
Alexa Jury
Anna Burford
Juliane M Jürgensmeier
Lawrence Doey
Ross Laxton
Safa Al-Sarraj
Sergey Popov
Suzanne E Little
P2860
P304
P356
10.1371/JOURNAL.PONE.0071777
P407
P50
P577
2013-08-21T00:00:00Z